And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. And our agenda is rather modest, despite the extended holiday weekend on this side of the pond. We plan to manicure the Pharmalot grounds, hang with our short person, promenade with the official mascots, and catch up on our reading. And what about you? This continues to be a lovely time to enjoy the great outdoors — there are beaches, lakes, and mountains to explore. You could make time for someone special or indulge in a few naps. Or prepare your bunker now that you-know-who called off peace talks. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you on Tuesday …
Most companies that pay six figures to the majority of their workers are not big banks or money managers, but biotech firms that rely on medical researchers, according to an analysis by The Wall Street Journal. Four companies in the S&P 500 paid workers in the middle of their payrolls more than $200,000, and three of them are drug makers. At Incyte (INCY), Celgene (CELG), and Vertex Pharmaceuticals (VRTX), the middle-earners last year made $253,000, $213,000 and $211,500, respectively.
About the Author Reprints
